OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Species differences in plasma protein binding of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) main protease inhibitor nirmatrelvir
Siennah R. Greenfield, Heather Eng, Qingyi Yang, et al.
Xenobiotica (2023) Vol. 53, Iss. 1, pp. 12-24
Closed Access | Times Cited: 5
Siennah R. Greenfield, Heather Eng, Qingyi Yang, et al.
Xenobiotica (2023) Vol. 53, Iss. 1, pp. 12-24
Closed Access | Times Cited: 5
Showing 5 citing articles:
A Second-Generation Oral SARS-CoV-2 Main Protease Inhibitor Clinical Candidate for the Treatment of COVID-19
Charlotte Allerton, Joel T. Arcari, Lisa Aschenbrenner, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 16, pp. 13550-13571
Open Access | Times Cited: 22
Charlotte Allerton, Joel T. Arcari, Lisa Aschenbrenner, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 16, pp. 13550-13571
Open Access | Times Cited: 22
A unifying model to explain frequent SARS-CoV-2 rebound after nirmatrelvir treatment and limited prophylactic efficacy
Shadisadat Esmaeili, Katherine Owens, Jessica Wagoner, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 7
Shadisadat Esmaeili, Katherine Owens, Jessica Wagoner, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 7
Species-Specific Unbound Fraction Differences in Highly Bound PFAS: A Comparative Study across Human, Rat, and Mouse Plasma and Albumin
Sangwoo Ryu, Woodrow Burchett, Sam Zhang, et al.
Toxics (2024) Vol. 12, Iss. 4, pp. 253-253
Open Access | Times Cited: 2
Sangwoo Ryu, Woodrow Burchett, Sam Zhang, et al.
Toxics (2024) Vol. 12, Iss. 4, pp. 253-253
Open Access | Times Cited: 2
Discovery of First Branched-Chain Ketoacid Dehydrogenase Kinase (BDK) Inhibitor Clinical Candidate PF-07328948
Kevin J. Filipski, Luis Martinez-Alsina, Matthew R. Reese, et al.
Journal of Medicinal Chemistry (2024)
Closed Access | Times Cited: 2
Kevin J. Filipski, Luis Martinez-Alsina, Matthew R. Reese, et al.
Journal of Medicinal Chemistry (2024)
Closed Access | Times Cited: 2
A unifying model to explain high nirmatrelvir therapeutic efficacy against SARS-CoV-2, despite low post-exposure prophylaxis efficacy and frequent viral rebound
Shadisadat Esmaeili, Katherine Owens, Jessica Wagoner, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 4
Shadisadat Esmaeili, Katherine Owens, Jessica Wagoner, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 4
